U.S., March 21 -- ClinicalTrials.gov registry received information related to the study (NCT07486453) titled 'Bioequivalence Study of Sacubitril Alisartan Amlodipine Tablets' on Feb. 27.
Brief Summary: This study aims to evaluate the bioequivalence and safety of single oral administration of Sacubitril/Valsartan/Amlodipine Tablets (240mg/5mg) versus Sacubitril/Valsartan Calcium Tablets (240mg) combined with Amlodipine Besylate Tablets (5mg) in healthy adult study participants.
Study Start Date: March 09
Study Type: INTERVENTIONAL
Condition:
Primary Hypertension
Intervention:
DRUG: Sequence A T-R-T-R
The medication sequence for sequence A is as follows: in the first and third cycles, the test formulation (T: Sacubitril Alesartan Amlo...